DPHAY News and Press, Dechra Pharms Plc Adr From 09/11/23

Blue Water Biotech Inc. (BWV) is expected to report $-0.12 for Q2 2023 Lycos Energy Inc (MAAL) is expected to report for quarter end 2023-06-30 Esports Entertainment Group Inc. (GMBL) is expected to report $-2.92 for Q4 2023 SigmaTron International Inc. (SGMA) is expected to report fo...

American Bio Medica Corp. (ABMC) is expected to report for Q1 2024 Fonar Corporation (FONR) is expected to report for Q1 2024 Bank Hapoalim B.M. ADR (BKHYY) is expected to report for Q2 2023 QualTek Services Inc. (QTEKQ) is expected to report for Q2 2023 BIMI International Medical...

Dechra Pharmaceuticals plc ADR (DPHAY) is expected to report for Q4 2023

2023-08-12 07:30:00 ET Summary Rondure Global Advisors is a women-owned investment adviser focused on high-quality equity investing for the long-term. We are deeply client-focused and actively cost-conscious, as we are heavily invested alongside our clients for the long haul. Both...

2023-07-30 07:10:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. Baron Small Cap Fund had a strong performance in Q2 2023, up 6.49% and up 16.54% for t...

2023-07-26 07:00:00 ET Summary Baron Health Care Fund invests in companies engaged in the research, development, production, sale, delivery, or distribution of products and services related to the healthcare industry. In the quarter ended June 30, 2023, Baron Health Care Fund adva...

2023-06-01 21:33:21 ET EQT AB is close to an agreement to purchase veterinary medicine company Dechra Pharmaceuticals ( OTCPK:DPHAY ). The Swedish private equity firm and Dechra are likely to announce a deal on Friday ahead of an extended deadline for the PE firm to either ma...

2023-04-13 13:30:22 ET Dechra Pharmaceuticals PLC ( OTCPK:DPHAY ) ADRs soared 45% after the company confirmed it was in talks with EQT in regard to a potential all-cash 4.63 billion pound ($5.8 billion) offer the UK-based veterinary pharmaceuticals firm. Dechra ( OTCPK:DPHAY...

Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. In the quarter ended June 30, 2022, Baron Health Care Fund declined 10.00% compared with the Benchmark. We are partic...

Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. Baron Growth Fund (the "Fund") declined 13.33% (Institutional Shares) during the quarter ended March 31, 2022. We foc...